TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Raphael J Landovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.